This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities

Title Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities
Abstract

Adrenomedullin (AM) is a 52-amino acid peptide with a pluripotential activity. AM is expressed in many tissues throughout the body, and plays a critical role in several diseases such as cancer, diabetes, cardiovascular and renal disorders, among others. While AM is a protective agent against cardiovascular disorders, it behaves as a stimulating factor in other pathologies such as cancer and diabetes. Therefore, AM is a new and promising target for the development of molecules which, through their ability to regulate AM levels, could be used in the treatment of these pathologies.

Apa Reference Julián, M., Cacho, M., García, M.A., Martín-Santamaría, S., de Pascual-Teresa, B., Ramos, A., Martínez, A. & Cuttitta, F. (2005). Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities. European Journal of Medicinal Chemistry, 40(8), 737-750. 10.1016/j.ejmech.2004.10.016
Doi 10.1016/j.ejmech.2004.10.016
Publication Date Aug 2005
Publication Type Article
Researcher Sonsoles Martin Santamaría
Ontology Drug Discovery and design
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home